Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 1.00 |
| ▸ | FAAH | O00519 | 5/20 | 0.64 |
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8780431 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL19281112 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL9565176 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL15994307 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL7924413 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL8660980 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL3318222 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL74418 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL5383341 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL23353 | 1.00 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1697 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| CN-121203552-B | Corrosion-resistant through silicon via copper film chemical mechanical polishing solution and application thereof | Xinyue Microelectronic Materials (Jiaxing) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260108440-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-04-23 | — | — | US | claimed |
| US-20260107944-A1 | HIGH HYALURONATE MULTI-PURPOSE DISINFECTION SOLUTIONS FOR OPHTHALMIC APPLICATIONS | CIS BIOPHARMA AG (CH) | 2026-04-23 | — | — | US | claimed |
| EP-4719612-A1 | RINSE-OFF HAIR COSMETIC COMPOSITIONS, METHOD OF TREATING HAIR, METHOD FOR PROVIDING IMPROVED CURLS DEFINITION TO THE HAIR AND USE OF A COMPOSITION | L'OREAL (FR) | 2026-04-08 | — | — | EP | claimed |
| EP-4716693-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2026-04-01 | — | — | EP | claimed |
| US-20260060909-A1 | HAIR CARE COMPOSITION COMPRISING TERTIARY AMIDOAMINES SURFACTANT (TAS), SALICYLIC ACID, FREE OF FATTY ALCOHOL AND PH= 6.5 | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
| US-20260047988-A1 | HAIR COSMETIC COMPOSITIONS AND METHOD OF TREATING HAIR | L'OREAL (FR) | 2026-02-19 | — | — | US | claimed |
| US-12527814-B2 | Treatment of an ocular infection, composition and methods thereof | THE UNIVERSITY OF HONG KONG (CN) | 2026-01-20 | — | — | US | claimed |
| US-12527327-B2 | High hyaluronate multi-purpose disinfection solutions for ophthalmic applications | CIS BIOPHARMA AG (CH) | 2026-01-20 | — | — | US | claimed |
| EP-0617953-B1 | Clear conditioning composition | CURTIS HELENE IND INC (US) | 1998-11-18 | — | — | EP | claimed |
| EP-0562639-B1 | Shampoo compositions and suspending agent therefor | CURTIS HELENE IND INC (US) | 1997-10-29 | — | — | EP | claimed |
| US-5665267-A | Shampoo compositions and suspending agent therefor | HELENE CURTIS, INC. (US) | 1997-09-09 | — | — | US | claimed |
| EP-0562637-B1 | Opacifier for water-based compositions | CURTIS HELENE IND INC (US) | 1997-05-28 | — | — | EP | claimed |
| US-5587154-A | COMPRISING A FATTY-TERT, SECONDARY- OR PRIMARY-AMINE AND AN ACID AS DISPERSANTS | HELENE CURTIS, INC. (US) | 1996-12-24 | — | — | US | claimed |
| US-5393519-A | Homogeneous; containing a conditioner | HELENE CURTIS, INC. (US) | 1995-02-28 | — | — | US | claimed |
| EP-0437006-B1 | Composition that protects dyed hair from fading | COLGATE PALMOLIVE CO (US) | 1994-12-07 | — | — | EP | claimed |
| EP-0562639-A1 | Shampoo compositions and suspending agent therefor | HELENE CURTIS, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| EP-0562637-A1 | Opacifier for water-based compositions | HELENE CURTIS, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| US-4283542-A | BY REACTING PHOSPHATE ESTER WITH AN AMINE TO PRODUCE AN AMPHOTERIC SURFACTANT | MONA INDUSTRIES (US) | 1981-08-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060909-A1 | HAIR CARE COMPOSITION COMPRISING TERTIARY AMIDOAMINES SURFACTANT (TAS), SALICYLIC ACID, FREE OF FATTY ALCOHOL AND PH= 6.5 | KRT18, ADH1A, ADH1C | DNM1 1954/4885FAAH 9/4885NAAA 837/4885 |
| US-20260107944-A1 | HIGH HYALURONATE MULTI-PURPOSE DISINFECTION SOLUTIONS FOR OPHTHALMIC APPLICATIONS | PKD2, CD44, HCN4 | DNM1 39/4885FAAH 1602/4885NAAA 262/4885 |
| US-12527327-B2 | High hyaluronate multi-purpose disinfection solutions for ophthalmic applications | CD44, HCN4, MUC1 | DNM1 16/4885FAAH 1191/4885NAAA 69/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | DNM1 3152/4885FAAH 364/4885NAAA 3538/4885 |
| US-20260047988-A1 | HAIR COSMETIC COMPOSITIONS AND METHOD OF TREATING HAIR | HCAR1, CUTA, HCAR3 | DNM1 3556/4885FAAH 276/4885NAAA 1851/4885 |
| US-20260108440-A1 | Personal Care Compositions | PBDC1, PIEZO1, TRPC7 | DNM1 4266/4885FAAH 2667/4885NAAA 1437/4885 |
| US-12527814-B2 | Treatment of an ocular infection, composition and methods thereof | Q6ZSR9, TMT1A, TBK1 | DNM1 372/4885FAAH 3651/4885NAAA 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.